Key facts
- Elevate Now’s last known valuation is $8.7M (Aug 2024).
- It has raised $3.4M; the latest was Early Stage VC ($2.0M) in Feb 2026.
- Notable investors include Inflection Point Ventures, Narayana Health, Physis Capital, Sriharsha Majety, Titan Capital (New York) — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Elevate Now
- ·The full record, as it builds
Funding rounds
No funding rounds for Elevate Now are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Elevate Now
Provider of a medical weight loss program intended to address the root cause of overweight issues. The company combines doctor-guided therapeutic interventions with personalized habit coaching, guidance on nutrition, fitness techniques, and stress management, enabling users to lose fat with clinical protocols developed by medical experts.
- Sector
- Healthcare
- HQ
- Delhi, India
- Founded
- 2022
- Employees
- 232
- Website
- joinelevatenow.com/
- Ownership
- Privately Held (backing)
Elevate Now doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Elevate Now shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Elevate Now in its N-PORT filings yet. We sweep new filings monthly.